Peer Review History
| Original SubmissionAugust 12, 2019 |
|---|
|
PONE-D-19-22766 Molecular assays to detect the presence and viability of Phytophthora ramorum and Grosmannia clavigera PLOS ONE Dear Dr Hamelin, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. We would appreciate receiving your revised manuscript by Oct 14 2019 11:59PM. When you are ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. To enhance the reproducibility of your results, we recommend that if applicable you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols Please include the following items when submitting your revised manuscript:
Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out. We look forward to receiving your revised manuscript. Kind regards, Simon Francis Shamoun, Ph.D. Academic Editor PLOS ONE Journal Requirements: 1. When submitting your revision, we need you to address these additional requirements. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at http://www.journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and http://www.journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf 2. Thank you for stating the following in the Financial Disclosure section: Grant from Genome Canada (10106) to RCH Grant from the Genomic Research and Development (GRDI) initiative to IL We note that one or more of the authors are employed by a commercial company: FPInnovations 1. Please provide an amended Funding Statement declaring this commercial affiliation, as well as a statement regarding the Role of Funders in your study. If the funding organization did not play a role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript and only provided financial support in the form of authors' salaries and/or research materials, please review your statements relating to the author contributions, and ensure you have specifically and accurately indicated the role(s) that these authors had in your study. You can update author roles in the Author Contributions section of the online submission form. Please also include the following statement within your amended Funding Statement. “The funder provided support in the form of salaries for authors [insert relevant initials], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the ‘author contributions’ section.” If your commercial affiliation did play a role in your study, please state and explain this role within your updated Funding Statement. 2. Please also provide an updated Competing Interests Statement declaring this commercial affiliation along with any other relevant declarations relating to employment, consultancy, patents, products in development, or marketed products, etc. Within your Competing Interests Statement, please confirm that this commercial affiliation does not alter your adherence to all PLOS ONE policies on sharing data and materials by including the following statement: "This does not alter our adherence to PLOS ONE policies on sharing data and materials.” (as detailed online in our guide for authors http://journals.plos.org/plosone/s/competing-interests) . If this adherence statement is not accurate and there are restrictions on sharing of data and/or materials, please state these. Please note that we cannot proceed with consideration of your article until this information has been declared. Please include both an updated Funding Statement and Competing Interests Statement in your cover letter. We will change the online submission form on your behalf. Please know it is PLOS ONE policy for corresponding authors to declare, on behalf of all authors, all potential competing interests for the purposes of transparency. PLOS defines a competing interest as anything that interferes with, or could reasonably be perceived as interfering with, the full and objective presentation, peer review, editorial decision-making, or publication of research or non-research articles submitted to one of the journals. Competing interests can be financial or non-financial, professional, or personal. Competing interests can arise in relationship to an organization or another person. Please follow this link to our website for more details on competing interests: http://journals.plos.org/plosone/s/competing-interests 3. We note that you have stated that you will provide repository information for your data at acceptance. Should your manuscript be accepted for publication, we will hold it until you provide the relevant accession numbers or DOIs necessary to access your data. If you wish to make changes to your Data Availability statement, please describe these changes in your cover letter and we will update your Data Availability statement to reflect the information you provide. 4. We note that you have included the phrase “data not shown” in your manuscript. Unfortunately, this does not meet our data sharing requirements. PLOS does not permit references to inaccessible data. We require that authors provide all relevant data within the paper, Supporting Information files, or in an acceptable, public repository. Please add a citation to support this phrase or upload the data that corresponds with these findings to a stable repository (such as Figshare or Dryad) and provide and URLs, DOIs, or accession numbers that may be used to access these data. Or, if the data are not a core part of the research being presented in your study, we ask that you remove the phrase that refers to these data. Additional Editor Comments: Dr. Richard Hamelin Professor, UBC- Vancouver, BC, Canada Bonjour Richard, Your manuscript Number PONE-D-19-22766: Molecular assays to detect the presence and viability of Phytophthora ramorum and Grosmannia clavigera, was critically reviewed by 5 external reviewers. Based on these reviews and my own assessment, I recommend publishing your manuscript after "Major Revision". I would like to draw your attention to address the comments/suggestions made by the reviewers. In particular, please, pay a close attention to reviews of the reviewers #1 and #5. I would like to review your revised version of your manuscript before considering it for publication. You have 45 days from August 30, 2019 to submit your revised version of the manuscript to PLOS ONE. Thank you for submitting your research results to PLOS ONE. We look forward to receiving your future research manuscripts. Best regards, Simon Simon Francis Shamoun, Ph.D Academic Editor PLOS ONE [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Partly Reviewer #2: Yes Reviewer #3: Yes Reviewer #4: Yes Reviewer #5: No ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes Reviewer #4: Yes Reviewer #5: N/A ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes Reviewer #4: Yes Reviewer #5: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes Reviewer #4: Yes Reviewer #5: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: This manuscript describes the design of molecular tools for the specific detection of genomic DNA and messenger RNA from two plant pathogens, i.e. the oomycete Phytophthora ramorum and the fungus Grosmannia clavigera. The novelty brought by this work is the design of species-specific tools on regions covering exon-intro junctions; in such a way that only cDNA retrotranscripted from mRNA is made amplifiable by PCR. The authors compared the amplification of coding regions of gDNA and corresponding mRNA in real-time PCR in several experimental trials, and showed that the level of mRNA decreased after mycelium treatment (e.g. heating) and could be used as a proxy for assessment of fungal or oomycete viability. The manuscript is well written, very easy to follow and overall well organized (although I suggest minor changes, see below). The discussion section is exhaustive and interesting, although more light is shed on P. ramorum. The experiments are adequate and compelling for most of the work, but I noticed a major discrepancy between what is claimed to be done and what is reported in the mat&met and results sections. In this respect, I recommend a major revision. Indeed, the abstract states that “a stability analysis was conducted by comparing the ratio of mRNA to gDNA overtime following heat treatment of wood infected by the oomycete..”. Also P12L244, it is written: “Ratio of ….applied to WOOD-LOGS infected with P. ramorum and G. clavigera”. However, in the experiments reported in the manuscript, only mRNA and gDNA from MYCELIAL cultures of the pathogen were heat-treated, not from WOOD infected by the latter (see §Heat treatment to determine mRNA stability”, P6-7; in Figure 4 caption “… for gDNA or cDNA extracted from CULTURES sampled from 0 to 240 hours after treatment.”), and in discussion section L285-287, L382. Likewise, all the discussion parts related to the appropriateness of wood treatments deserve mitigation since the experiments carried out in this work only dealt with in vitro-cultivated mycelium and not in vivo growing mycelium. The efficiency of heat treatment procedures are dependent of wood thickness, relative humidity, heat flow, etc. I therefore suggest clarifying what was really assessed in this work. It seems that artificially infected wood were indeed tested after 28 days of incubation, but not after the two different heat treatments. Specific comments: L46: Ref 8 and 9 do not seem to be the most relevant ones to support the statement of the sentence. L50: again here, ref 11 does not seem to be appropriate to the support the statement. L69: ref 21 and 22 are more appropriate here, ref 20 a bit less supporting. Consider removing it. L79 and 90: please could you explain why distinct DB were used for the selection of genes? L82: on which basis the genes were selected? It is written “genes are expected to be expressed”, but how was that anticipated? The discussion section contains important information pertaining to the rationale followed for the selection, and this information should be moved to the mat&met section. L133: number, reference of isolates and number of replicates should better be indicated here, rather than in a later paragraph (L177-179). L140-141: the sentence sounds a bit odd. L147: please specify what the wood samples were collected from. L177: how was the qPCR done with these solutions as templates? 2.2 ng of template DNA are indicated a few lines above. Is it still the case? Figure 1 caption indicates that gDNA and cDNA were used, but it is in conflict with what is written L215-216. L201: is there one single sister species (L. longiclavatum) or several involved here? Not clear what “these sister species” refer to. Figure 3 should remind how many replicates were included, and also explain how the curves should be interpreted (shaded areas, min and max?). Also, it should be interesting to discuss the striking lower magnitude of fluorescence yielded with cDNA extracted from P. ramorum-infected Tsuga, whereas the gDNA curves look “normal”. I noticed that there was a change of y-axis scale compared to the other plots, probably in order to better fit the gDNA fluorescence magnitude. But still, the gDNA/cDNA difference with the other plots seems awkward. L239: I do not think that it is relevant to compare the mean Ct values obtained with chlamydospores to those obtained with infected wood samples. Chlamydospores quantity was arbitrarily set, we do not know if is close to reality in infected tissue or soil for instance. Table 1: consider removing it, as it is a piece of arid stats. Or maybe replace “treatment” with what it stands for. L285: heat treatment may just not degrade mRNA, it may also inhibit its synthesis. L367-L372: I fully agree with this caveat. The authors should therefore recommend a practical procedure to assess the kinetics of mRNA. Figure 4: The authors should discuss some questioning variations observed in cDNA quantity, e.g. the high variation in cDNA amplification between Ctrl/ 0 and 24 hrs post treatment for P. ramorum/short heat treatment. Although it seems obvious that after a certain treatment duration, no mRNA is produced, what would explain this high variation before that time? One may also wonder why gDNA and cDNA quantities (inferred from Ct values) in the control are sometimes significantly superior to the 0 tpt values? In two occasions, no mRNA is detected at all for 0 tpt, whereas the ctrl value is “normal”. Is it because 0 means that the treatment already started? If yes, 0 is propably not appropriate term. More general comments: The discussion section is a lot about P. ramorum, and unfortunately G. clavigera is a bit set aside. Although G. clavigera is less “famous” than P. ramorum, a more balanced discussion would be nice. Reviewer #2: This manurscript is very appropriate for PLOS ONE. The manuscript is well written and present a new molecular assay using mRNA and gDNA to detect and show viability of Phytophthora ramorum and Grosmania clavigera. The method is well described and present new material. The 2 assays seem to work very well and could serve as base for ID and evaluation of viability of forest pathogens. The genomic was used to ID markers and selection of junction of intron/exon was good choice and well presented. The discussion could have more information comparing other methods and talk about the limitation of the assays, by example the detection of mRNA is very at the Ct value of limit of detection. What about other assays published. Other missing or clarifying information need to be add. Specific comments: P4L58 did you consider to add other method information to look at viability, I believe the PMA Propodium monoazide is a good method and do not need to play with RNA. Should add info and pro and cons in discussion? P4L69 I was wondering about if the P. ramorum was infecting in wood or surface but was more clear later in manuscript. Could be presented more here. P5L82, it is really a communication or more a resource? (Bret Tyler sequences) P6L104 for G. clavigera, only one isolate was use, how do we know it would work with multiple genotypes? P6L109 any reason on use of only conifers, what about deciduous tree for P. ramorum? P6L115 any specific reference for the SPF kiln drying schedule? P8L144 "Matric" should be "Matrix" Correct in line 154. P9L178 "586 and 101329) info on specimens, it is voucher isolate, CBS culture??? need more info on you isolates used in the manuscript? P9 Just wondering it is better ration Ct or Ration concentration calculated, Ct,Log10? P12L232, 33.4 seem to be very low limit? not so high you may miss lower concentration of pathogens. also should explain the range in figure 3, blurry red?? Blurry blue, same Ct but range blurry?? not clear what it mean? P12L247 and Table 1, not so clear what the F, Fvalue is the stat need to be better explained and significance in the manuscript? Table 1 no footnotes, what the "*" means? By? Tyope III SS? Discussion, RNA extraction and cDNA is additional step, add info how the RNA extraction is easy or difficult and cDNA prep, risk of contamination, compare to PMA should be discuss. What is the Ct level limit for cDNA-mRNA in other publication using similar approach? Reviewer #3: In this MS, development of a PCR-based viability assay of tree pathogens is described. The authors showed that both genomic DNA and mRNA extracted from tree tissues under the bark were amenable for qPCR. They also showed that heat treatments could effectively kill the pathogens. Effectiveness of the heat treatments on the pathogens growing in the wood trunk was, however, not evaluated. The author needs to address this point. Below are my specific comments. Line 18: RNA represents ... therefore only be produced by living organisms. <comment> RNA, as well as DNA, are only produced by living organisms. Line 164: cDNA synthesis <comment> The authors used two-step RT-qPCR for all samples. The two-step method, which uses a stock cDNA, may be advantageous for the screening of primer pairs. However, for high-throughput assay, one-step RT-qPCR is more advantageous and give less experimental variation. Line 231: Cycle-threshold values obtained for the cDNA were slightly higher. <comment> For both P. ramorum and G. clavigera, the differences of Ct values between gDNA and cDNA were over 3, which were equivalent to an 8-fold difference in copy number of templates. This is a huge difference and needs to be discussed. Line 242: No amplification was observed in the no-template control. <comment> The vast quantity of genomic DNA and cDNA from inoculated wood samples were of the host plant origin. What was the level of background amplification when a DNA template from a non-inoculated plant tissue was used? Line 342: indicating that the target gene is still expressed during this life-stage. <comment> Most likely, the target gene is not expressed in the resting spores, but its transcript is stored in them. Reviewer #4: This is an interesting manuscript describing a novel approach to the development of real-time PCR assays for viable pathogens in wood, providing significant improvements to current methods used in screening wood products. In particular the focus on only detecting viable pathogens (linked to the decay of mRNA) is valuable and will likely be applied in plant diagnostics. The manuscript is very well written, relatively free of grammatical and spelling errors (see short list below), and the statistical analyses appear sound. The real time PCR data depicted in Fig 3 is however a bit troubling, with regard to the Ct values. The authors should mention the instrument used in the assays in the Methods section, L 170-176, and how the thresholds were established for Ct calculations. A more precise estimation of the Ct could improve upon the degree of error in their data (e.g. Fig. 4). Were instrument default parameters used in Ct calls, or did the authors adjust these parameters? Again, please state how this was set on the instrument in the Methods section. The cDNA reactions and Ct values illustrated in Fig 3 appear to be calling the Ct rather inconsistently between the samples, and this would affect the ratio and perhaps improve the error estimations. The authors should consider that Ct values over 32-33 are considered to be late amplification and may be non-specific, or at least represent an extremely low target cDNA copy number. The authors could confirm that the high Ct values are not artefactual with e.g. information from melt curves. The primers and reactions perform well using cDNA generated from pathogen RNA, but the amplifications in wood-extracted samples appears to be very weak. Paragraph #5 of the Discussion L 345-376 should be re-written for clarity and consistency. The paragraph is very long, and wanders a bit from the first sentence (L345-346), a rather simplistic declaration, to later discussion of the reliance of the technique on the kinetics of mRNA stability (L 371 to 376). The paragraph could be reduced in length and the paragraph structure improved for clarity of the points made. In addition, a few minor edits to the manuscript are recommended: L63 insert “in eukaryotes” L 134-136 “falcon” filters and tubes- Falcon is a brand not a type of tube- e.g. describe as “50 mL conical plastic centrifuge tube” or some such. L 161 “Qubit fluorometer” list source L 218 How was amplification efficiency calculated from the regression curves? L236 synthesized (sp) L 239 nucleic acids (no hyphen) L255 ...efficiently killed... (reverse order of words) Reviewer #5: The authors report new cDNA-based reverse transcription quantitative real time PCR (RT-qPCR) assays to detect the presence and viability of Phytophthora ramorum and Grosmannia clavigera. The authors test the ability of the assay to discriminate between living and dead fungal samples after two heat treatments. Additionally, the assay is used to detect the pathogens in artificially inoculated wood bolts. The main merit of the publication is in developing molecular assays that can distinguish between dead and living mycelium based on cDNA/gDNA ratios. Assays that can evaluate pathogen viability have potential to improve phytosanitary measures. The P. ramorum assay is promising as a diagnostic tool, as it only amplifies P. ramorum DNA, and not other closely related species from Phytophthora clade 8c. However, the G. clavigera assay is not fully specific as it amplifies a closely related species: L. longiclavatum. This is problematic in terms of specific pathogen identification for diagnostic purposes. The impact of the work would be higher if the assay was specific for G. glavicera. Alternatively, the authors could develop an assay that robustly detects several closely related Leptographium/Grossmannia species. The experimental design that was used to test the assay has some flaws and inconsistencies: - The data for the heat treatments may not be fully comparable. Mycelial samples were processed differently for the two heat treatments: in kiln-drying, the authors used 0.1 ml tubes in a heat block, whereas in short heat treatment, they used agar plates in an oven. This might affect fungal viability and thus RNA degradation. The authors should provide data that shows this has no effect on the Cq values. Now, the ANOVA cannot distinguish if this affects the cDNA/gDNA ratios. - No control mycelium samples for the different time points. As this is a time-point assay, the authors should include a non-treated control mycelium sample for each time point, and store them in identical conditions as the treated samples. This would tell if the expression of the gene target is actually stable in the used conditions, and would help to evaluate the suitability of this assay as a diagnostic tool. - Wood samples were not plated to reisolate the pathogen. This would provide a concrete reference point to discuss the ability of the assay to detect the pathogens, either viable or dead. - Wood samples were not compared for the heat treatments. This would have been an excellent simulation for the relevance of the assay as a diagnostic tool. Now the work falls short of demonstrating the applicability of this assay in phytosanitary screening. - Imbalanced sample sizes for the two pathogens: 8 P. ramorum isolates, but only 1 G. clavigera isolate. In my opinion, the authors should have used more G. glavigera isolates. Additionally, there are some concerns related to RNA sample quality control. The authors only used Nanodrop to quantify the RNA samples before DNAse treatment, which can distort the downstream RNA amounts added to the reverse transcription reactions. They used a kit that selects for RNA, but still, fluorescent RNA-binding dyes are the preferred method to get accurate RNA concentrations. Additionally, the authors do not report any method that was used to estimate RNA integrity (Nanodrop is not sufficient). The manuscript has potential, but I cannot recommend the acceptance of this manuscript in its current form. The authors would need to make complementary experiments and provide more data to improve the manuscript. Especially I would like to see data for the effect of the heat treatment on the wood samples and pathogen viability, and how the assay performs as a diagnostic tool. Alternatively, the authors should re-analyze the data and re-write it as a short communication and tone down the role of the heat treatment comparison. This would in my opinion require excluding/re-developing the G. clavigera assay, as it is not species specific, but it is not a broad-spectrum assay either. Comments and revisions See PDF for language revisions Please read Bustin et al. 2009 (10.1373/clinchem.2008.112797) for recommended terminology and experimental guidelines for quantitative PCR experiments Correct real-time PCR to quantitative real-time PCR (qPCR) Correct reverse transcription real-time PCR (RT-PCR) to reverse transcription quantitative PCR (RT-qPCR) Correct Threshold cycle/Cycle threshold (Ct) to Quantification cycle (Cq) throughout the manuscript Resolution of all figures is poor. Make sure you provide figure files with at least sufficient resolution (TIFF files with 300-600 DPI) and export graphs from R-studio/statistical software into EPS format to get 300 DPI resolution (see journal guidelines for preparing the images). L47: What do you mean by universal genes? Conserved genes? L78: How many conserved proteins, how many sequences? L85-88: Rephrase to list P. ramorum as the primers were also tested on P. ramorum. L94: Rephrase to list G. clavicera as the primers were also tested on G. clavicera. L98-99: Provide citation to manuals/protocols/guidelines that were used to optimize the assays. L113-131: The experimental setting is unclear. Please make an illustration showing the workflow, with heat treatments, what samples were used for what, differences in methods, replicates, controls, plating etc. L103-104: Why did you decide to use 8 isolates of P. ramorum and only one G. clavicera isolate? This is a rather unbalanced experimental setting. L103-112: How many bolts per each tree species-pathogen-time point combination? L102-112: Why did you not plate any of the wood tissue? This would provide a reference point to evaluate what the re-isolation success is in controls vs. after heat treatment, and if the pathogens remain viable after the treatments. The manuscript would be improved if the authors provided results for re-isolation from inoculated wood samples. L102-112: Why you did not use any of the wood samples for the heat treatments? This would be the closest to a real life simulation to evaluate the efficacy of the heat treatments. Now the results have very little connection to using the assay in a real-life diagnostic context. L105: Provide ingredients or citation for carrot and MEA media L118: Provide ingredients or citation for V8 and MEA media L114-123: At what temperature were the samples stored after the SPF kiln-drying treatment before sample collection? L120-121: Was the frozen mycelium sample in 1.5 ml tubes the only control? Did you have untreated controls stored in 0.1 ml strip tubes that were stored in same conditions as the heat treated samples, and sampled at the same time points? Flash freezing preserves mRNA better compared to a situation where a small non-heat-treated sample of mycelium is stored at room temperature. Now it is not clear how much RNA degradation occurs due to storage at room temperature, and how much is due to heat treatment. Additionally, knowing the expression of the gene over several time points would help to evaluate the suitability of this gene as a diagnostic marker. Please provide data for cDNA/gDNA ratios for control mycelial samples that are stored and sampled similarly to the heat-treated samples. L127-129: For the short heat treatment, did you put agar plates directly to the oven? This might be a problem in terms of comparing the heat treatments. The mycelium on the plates might be heated differently than in the SPF kiln-drying treatment, where 0.1 ml Eppendorf tubes were used for heating and storing the samples after the treatment. Can you provide data that would indicate this won’t affect the degradation rate of mRNA? I would repeat this experiment by placing the mycelium into 0.1 ml Eppendorf tubes, perform the short heat treatment, and sample similarly as in the SPF kiln-drying experiment. With the current methods, I am not convinced that the data from the two heat treatments is comparable. The ANOVA won’t be able to tell if the differences in cDNA/gDNA ratios are caused by using 0.1 ml tubes vs. plates, or due to different temperature treatment, as the use of tubes or plates is nested within the heat treatment. L159-163: Why did the authors decide to use two different methods for quantification of nucleic acids, Qubit for DNA and Nanodrop for RNA? Per MIQE guidelines, the preferred method for quantifying RNA uses fluorescent RNA-binding dyes, e.g. Qubit assay. As the RNA is not pure mRNA and the concentrations were measured before DNAse treatment, it is likely that Nanodrop readings overestimate the concentrations. This can affect the amount of RNA that is added to each RT reaction. Please address this issue and provide data that shows you get the similar Cq results from RNA samples measured with Qubit. L159-163: What method did you use to evaluate RNA integrity? The absorbance values from Nanodrop only indicate RNA sample purity, not integrity. L170-176: How many biological and technical replicates? L204-208: Based on previous data, does the gene have stable constitutive expression? For diagnostic assays like the authors are developing, the gene targets should have stable expression no matter the condition. Add eg. text and references from lines 337-339. L221-223: Figure 2 caption: Revise so that you provide the same information for both targets and indicate clearly which gene target is for which pathogen. L234-238: Figure 3 caption: Indicate what the shaded areas are. L250-261: Report results from statistical testing, as they are not indicated in Figure 4 or elsewhere. L255-257: Less efficient compared to what: control, the other treatment? Be more specific. L267-268: Table 1 indicates that replicate has a significant impact on G. clavicera cDNA/gDNA ratios. Discuss why this is observed for G. clavicera but not for P. ramorum? How was the quality of the RNA samples? How about lesion lengths, any variation in that? L272-275: Summarize the results in 1-2 sentences in appropriate context. This is not re-isolation because what you describe is plating mycelium samples prepared from the same known pure culture. Rather you are assessing viability of mycelium after heat treatment. L272-275 & L345-376: If I understand correctly, you did not make any re-isolations from the bolts. Discuss/Explain why not? Discuss if plating only the heat-treated mycelium samples provides a reliable reference for the viability of the pathogen in biological samples. How do the Cq values for mRNA in colonized bolts and mycelial samples compare? Based on the Cq values, what is the extent of mycelial colonization in the wood samples? L312: At least in the US, by definition the pathogen is not regulated, but the interstate movement of certain articles from quarantined counties is regulated. See for details: https://www.federalregister.gov/documents/2007/02/27/07-892/phytophthora-ramorum-quarantine-and-regulations L367-376: Be a bit critical and discuss if this could be resolved by plating infected wood samples after the heat treatments. There might be a time window after the treatment when the pathogen would still be able to grow, if suitable conditions (e.g. nutrients, temperature, moisture) were available. In what conditions are heat-treated/kiln-dried samples stored in industrial facilities? Is there a risk that the pathogen would still remain infectious? Does this create a risk for false-negatives? When should the diagnostic testing be done? Is this feasible? Discussion and criticism lacks entirely for the non-specific G. clavigera assay. Discuss what diagnostic implications this might have, if you are not willing to expand the work and develop an assay that is specific for this pathogen. Are all Grosmannia/Leptographium species equally harmful? Could this assay be a more generic assay that detects several of these species? </comment></comment></comment></comment></comment> ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No Reviewer #3: No Reviewer #4: No Reviewer #5: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files to be viewed.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at figures@plos.org. Please note that Supporting Information files do not need this step.
|
| Revision 1 |
|
Molecular assays to detect the presence and viability of Phytophthora ramorum and Grosmannia clavigera PONE-D-19-22766R1 Dear Dr. Richard Hamelin, We are pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it complies with all outstanding technical requirements. Within one week, you will receive an e-mail containing information on the amendments required prior to publication. When all required modifications have been addressed, you will receive a formal acceptance letter and your manuscript will proceed to our production department and be scheduled for publication. Shortly after the formal acceptance letter is sent, an invoice for payment will follow. To ensure an efficient production and billing process, please log into Editorial Manager at https://www.editorialmanager.com/pone/, click the "Update My Information" link at the top of the page, and update your user information. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to enable them to help maximize its impact. If they will be preparing press materials for this manuscript, you must inform our press team as soon as possible and no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. With kind regards, Simon Francis Shamoun, Ph.D. Academic Editor PLOS ONE Additional Editor Comments (optional): Dr. Richard Hamelin Professor of Forest Pathology University of British Columbia Department of Forest Sciences Vancouver, BC, Canada Dear Dr. Hamelin, I have reviewed your revised version of the manuscript entitled: "Number PONE-D-19-22766R1- "Molecular assays to detect the presence and viability of Phytophthora ramorum and Grosmannia clavigera" and found it acceptable for publication in PLOS ONE. Based on my expertise and the reviews of the five external reviewers, I recommend publishing your revised version of your manuscript in PLOS ONE. At this time, on behalf of PLOS ONE, I would like to congratulate you and your co-authors on this outstanding research work and results. I commend you and your research team for this achievement. We look forward to receiving future research articles from you and your research team. Best regards, Dr. Simon Francis Shamoun Academic Editor PLOS ONE Reviewers' comments: |
| Formally Accepted |
|
PONE-D-19-22766R1 Molecular assays to detect the presence and viability of Phytophthora ramorum and Grosmannia clavigera Dear Dr. Hamelin: I am pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please notify them about your upcoming paper at this point, to enable them to help maximize its impact. If they will be preparing press materials for this manuscript, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. For any other questions or concerns, please email plosone@plos.org. Thank you for submitting your work to PLOS ONE. With kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Simon Francis Shamoun Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .